Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ISRG Stock Forecast 2026-2027
$469.21
Current Price
$166.65B
Market Cap
Buy 24
Hold 9
Sell 2
Wall St Analyst Ratings
Distance to ISRG Price Targets
+59.8%
To High Target of $750.00
+29.9%
To Median Target of $609.50
-19.4%
To Low Target of $378.00
ISRG Price Momentum
+4.1%
1 Week Change
-2.2%
1 Month Change
-2.8%
1 Year Change
-17.2%
Year-to-Date Change
-22.3%
From 52W High of $603.88
+9.7%
From 52W Low of $427.84
📊 TOP ANALYST CALLS
Did ISRG Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Intuitive Surgical is one of their latest high-conviction picks.
Latest ISRG Stock Price Targets & Analyst Predictions
Based on our analysis of 44 Wall Street analysts, ISRG has a bullish consensus with a median price target of $609.50 (ranging from $378.00 to $750.00). The overall analyst rating is Strong Buy (8.2/10). Currently trading at $469.21, the median forecast implies a 29.9% upside. This outlook is supported by 24 Buy, 9 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Lee Hambright at Bernstein, projecting a 59.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ISRG Analyst Ratings
24
Buy
9
Hold
2
Sell
ISRG Price Target Range
Low
$378.00
Average
$609.50
High
$750.00
Current: $469.21
Latest ISRG Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ISRG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 15, 2026 | Truist Securities | Richard Newitter | Buy | Maintains | $580.00 |
| Apr 13, 2026 | Mizuho | Anthony Petrone | Neutral | Maintains | $525.00 |
| Apr 10, 2026 | BTIG | Ryan Zimmerman | Buy | Reiterates | $616.00 |
| Apr 9, 2026 | Goldman Sachs | David Roman | Buy | Maintains | $609.00 |
| Apr 6, 2026 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $480.00 |
| Mar 17, 2026 | UBS | Andre Salles | Neutral | Maintains | $550.00 |
| Mar 11, 2026 | Citigroup | Joanne Wuensch | Buy | Upgrade | $590.00 |
| Feb 24, 2026 | UBS | Andre Salles | Neutral | Maintains | $570.00 |
| Jan 27, 2026 | Freedom Capital Markets | Buy | Upgrade | $610.00 | |
| Jan 27, 2026 | TD Cowen | Mathew Blackman | Buy | Initiates | $660.00 |
| Jan 26, 2026 | Barclays | Matt Miksic | Overweight | Maintains | $712.00 |
| Jan 26, 2026 | Freedom Broker | Buy | Upgrade | $N/A | |
| Jan 23, 2026 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $550.00 |
| Jan 23, 2026 | BTIG | Ryan Zimmerman | Buy | Reiterates | $616.00 |
| Jan 23, 2026 | Bernstein | Lee Hambright | Outperform | Maintains | $750.00 |
| Jan 23, 2026 | Piper Sandler | Adam Maeder | Overweight | Maintains | $620.00 |
| Jan 23, 2026 | Citigroup | Joanne Wuensch | Neutral | Maintains | $590.00 |
| Jan 9, 2026 | Bernstein | Lee Hambright | Outperform | Maintains | $740.00 |
| Jan 7, 2026 | Barclays | Matt Miksic | Overweight | Maintains | $686.00 |
| Jan 7, 2026 | BTIG | Ryan Zimmerman | Buy | Maintains | $616.00 |
Intuitive Surgical, Inc. (ISRG) Competitors
The following stocks are similar to Intuitive Surgical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ISRG
Intuitive Surgical
mkt cap
166.65B
Intuitive Surgical, Inc. (ISRG) Financial Data
Intuitive Surgical, Inc. has a market capitalization of $166.65B with a P/E ratio of 59.5x. The company generates $10.06B in trailing twelve-month revenue with a 28.4% profit margin.
Revenue growth is +18.8% quarter-over-quarter, while maintaining an operating margin of +30.2% and return on equity of +16.7%.
Valuation Metrics
Market Cap
$166.65B
Enterprise Value
$160.68B
P/E Ratio
59.5x
PEG Ratio
3.6x
Price/Sales
16.5x
Growth & Margins
Revenue Growth (YoY)
+18.8%
Gross Margin
+66.4%
Operating Margin
+30.2%
Net Margin
+28.4%
EPS Growth
+15.9%
Financial Health
Cash/Price Ratio
+3.6%
Current Ratio
4.9x
Debt/Equity
1.0x
ROE
+16.7%
ROA
+9.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Intuitive Surgical, Inc. (ISRG) Business Model
About Intuitive Surgical, Inc.
What They Do
Develops robotic-assisted surgical systems for healthcare.
Business Model
The company generates revenue primarily through the sale of its da Vinci surgical systems, along with the associated instruments and accessories used in surgeries. Additionally, Intuitive Surgical offers maintenance services and digital solutions, which further contribute to its income stream by enhancing the efficiency and effectiveness of surgical procedures.
Additional Information
Founded in 1995 and based in Sunnyvale, California, Intuitive Surgical is a leader in minimally invasive care and is involved in a wide range of surgical specialties. Its focus on innovation aims to improve surgical outcomes, patient experiences, and reduce healthcare costs, while expanding access to advanced surgical technologies.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
17,021
CEO
Mr. David J. Rosa
Country
United States
IPO Year
2000
Website
www.intuitive.comIntuitive Surgical, Inc. (ISRG) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
ISRG's Rising Procedure TAM With Low Penetration Backs Sustained Growth
ISRG expects its addressable procedures to reach 9 million by 2026, pointing to a significant growth runway as robotic surgery adoption remains nascent.
Apr 17, 2026
By Indrajit Bandyopadhyay
Analyst Blog
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: Here's Why
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $458.08, moving 2.19% from the previous trading session.
Apr 16, 2026
By Zacks Equity Research
Tale of the Tape
Intuitive Surgical Pre-Q1 Analysis: Buy, Hold or Sell the Stock Now?
Intuitive Surgical faces a key test as earnings near, with strong procedure growth and da Vinci 5 adoption offset by pricing pressure and valuation concerns.
Apr 16, 2026
By Indrajit Bandyopadhyay
Analyst Blog
Latest News
Intuitive Surgical Is Jumping 2.7% Ahead of Earnings. Is the Robotics Stock Ready to Recover?
2 days ago
Quick Summary
Intuitive Surgical (NASDAQ: ISRG) will announce its Q1 2026 results on April 21, after market close.
Why It Matters
Upcoming Q1 2026 results from Intuitive Surgical may impact stock performance and investor sentiment, influencing trading decisions and market forecasts.
Source: 24/7 Wall Street
Market Sentiment:
Neutral
Quick Summary
ISRG anticipates its addressable procedures will increase to 9 million by 2026, indicating strong growth potential in the robotic surgery market.
Why It Matters
ISRG's projected growth in addressable procedures indicates expanding market potential and increased revenue opportunities as robotic surgery adoption accelerates.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Netflix showed strong performance as concerns over a Warner Bros. Discovery acquisition eased. Microsoft underperformed despite robust results, affected by Azure growth and AI investments. Alnylam Pharmaceuticals is well-positioned for long-term growth.
Why It Matters
Netflix's strong performance eases acquisition fears, potentially boosting its stock. Microsoft’s Azure concerns may hinder growth perception. Alnylam's promising pipeline suggests robust future potential.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Intuitive Surgical, known for its da Vinci robotic surgery system, is positioned to benefit from the aging population trend, profiting from both system sales and ongoing usage.
Why It Matters
Intuitive Surgical's dual revenue model from system sales and ongoing usage positions it well to capitalize on the growing demand for healthcare services due to an aging population.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
Intuitive Surgical, Inc. (ISRG) closed at $467.22, up 1.8% from the previous trading day in the latest session.
Why It Matters
Intuitive Surgical's 1.8% increase signals positive market sentiment and potential investor confidence, which may influence future trading and valuation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Intuitive Surgical (ISRG) is expected to report its Q1 2026 performance. Investors should consider key metrics beyond Wall Street's revenue and earnings estimates for deeper insights.
Why It Matters
Analyzing Intuitive Surgical's key metrics offers a clearer view of its growth potential and operational efficiency, influencing investment decisions and stock valuation.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Frequently Asked Questions About ISRG Stock
What is Intuitive Surgical, Inc.'s (ISRG) stock forecast for 2026?
Based on our analysis of 44 Wall Street analysts, Intuitive Surgical, Inc. (ISRG) has a median price target of $609.50. The highest price target is $750.00 and the lowest is $378.00.
Is ISRG stock a good investment in 2026?
According to current analyst ratings, ISRG has 24 Buy ratings, 9 Hold ratings, and 2 Sell ratings. The stock is currently trading at $469.21. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ISRG stock?
Wall Street analysts predict ISRG stock could reach $609.50 in the next 12 months. This represents a 29.9% increase from the current price of $469.21. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Intuitive Surgical, Inc.'s business model?
The company generates revenue primarily through the sale of its da Vinci surgical systems, along with the associated instruments and accessories used in surgeries. Additionally, Intuitive Surgical offers maintenance services and digital solutions, which further contribute to its income stream by enhancing the efficiency and effectiveness of surgical procedures.
What is the highest forecasted price for ISRG Intuitive Surgical, Inc.?
The highest price target for ISRG is $750.00 from Lee Hambright at Bernstein, which represents a 59.8% increase from the current price of $469.21.
What is the lowest forecasted price for ISRG Intuitive Surgical, Inc.?
The lowest price target for ISRG is $378.00 from at , which represents a -19.4% decrease from the current price of $469.21.
What is the overall ISRG consensus from analysts for Intuitive Surgical, Inc.?
The overall analyst consensus for ISRG is bullish. Out of 44 Wall Street analysts, 24 rate it as Buy, 9 as Hold, and 2 as Sell, with a median price target of $609.50.
How accurate are ISRG stock price projections?
Stock price projections, including those for Intuitive Surgical, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 19, 2026 5:30 PM UTC